Swiss Re AG (SREN) Given a CHF 92 Price Target by Commerzbank Ag Analysts
Swiss Re AG (VTX:SREN) has been given a CHF 92 price objective by Commerzbank Ag in a report released on Thursday. The brokerage currently has a “sell” rating on the stock.
Other equities research analysts have also recently issued reports about the company. Royal Bank Of Canada reaffirmed a “buy” rating on shares of Swiss Re AG in a research report on Friday, August 4th. Deutsche Bank AG set a CHF 104 price objective on Swiss Re AG and gave the company a “buy” rating in a research report on Tuesday, July 25th. Morgan Stanley set a CHF 104.30 price objective on Swiss Re AG and gave the company a “buy” rating in a research report on Friday, July 21st. J P Morgan Chase & Co set a CHF 111 price objective on Swiss Re AG and gave the company a “buy” rating in a research report on Monday, July 10th. Finally, DZ Bank AG reaffirmed a “buy” rating on shares of Swiss Re AG in a research report on Monday, August 7th. Three analysts have rated the stock with a sell rating, nine have issued a hold rating and seven have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of CHF 94.13.
COPYRIGHT VIOLATION WARNING: This report was originally published by American Banking News and is the property of of American Banking News. If you are reading this report on another site, it was illegally copied and republished in violation of international copyright and trademark legislation. The correct version of this report can be read at https://www.americanbankingnews.com/2017/11/02/swiss-re-ag-sren-given-a-chf-92-price-target-by-commerzbank-ag-analysts.html.
About Swiss Re AG
Swiss Re AG is a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. The Company operates in four segments: Property&Casualty Reinsurance, Life&Health Reinsurance, Corporate Solutions and Life Capital. Its Reinsurance Unit provides premiums and fee income through Property&Casualty and Life&Health segments.
Receive News & Ratings for Swiss Re AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swiss Re AG and related companies with MarketBeat.com's FREE daily email newsletter.